Liver Disease in Dogs: Signs, Jaundice, and Treatment Guide

The liver is one of those organs that earns very little attention until it stops working properly. It performs over 500 distinct metabolic functions: filtering toxins from the blood, producing bile for digestion, synthesizing clotting factors and albumin, metabolizing drugs, and storing glycogen for energy. A dog's liver has extraordinary regenerative capacity, which means early disease can progress silently for months before clinical signs emerge. By the time a pet is visibly unwell, the disease is often well established.

Liver disease in dogs spans from the mundane, an incidental enzyme elevation on routine bloodwork that resolves without treatment, to the catastrophic, fulminant hepatic failure requiring emergency hospitalization. Between those poles lies a wide clinical spectrum that rewards early investigation and penalizes indefinite watchful waiting. Understanding the signs of liver disease in dogs, what elevated liver enzymes actually indicate, and what jaundice signals in practice gives owners the framework to make faster, better-informed decisions when something is wrong.

What to Know Two-year mortality in dogs following hepatic biopsy diagnosis reaches 45.6%, and five-year mortality rises to 78.9%, underscoring that liver disease in dogs is frequently progressive (PMC10451749, 2023). The key prognostic advantage is early diagnosis before complications such as jaundice, ascites, or hepatic encephalopathy develop. Most forms of liver disease are not curable, but many are manageable for months to years when identified and addressed at the right stage.

What Does the Liver Actually Do?

Understanding what the liver does makes the clinical signs of its failure considerably easier to interpret. The organ sits in the cranial abdomen, just behind the diaphragm, and receives a dual blood supply: oxygenated blood from the hepatic artery, and nutrient-rich blood from the portal vein draining the gastrointestinal tract. This position makes the liver both the body's primary chemical processing plant and the first organ to encounter anything absorbed from the gut.

Hepatocytes, the primary liver cells, are responsible for most metabolic functions. They synthesize plasma proteins including albumin (which maintains oncotic pressure and transports drugs and hormones), clotting factors (II, VII, IX, X), and acute-phase proteins. They metabolize and conjugate bilirubin, the breakdown product of heme from red blood cells, and secrete it into bile for excretion. They convert ammonia, a toxic byproduct of protein metabolism, into urea for renal excretion. And they detoxify drugs, environmental chemicals, and microbial products absorbed from the intestine.

Damage to hepatocytes releases alanine aminotransferase (ALT) and aspartate aminotransferase (AST) into the bloodstream. Cholestasis, or impaired bile flow, releases alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT). These enzyme elevations on bloodwork are not measures of liver function, they are markers of liver cell injury or bile duct stress. Function itself is assessed differently, through albumin, bilirubin, clotting times, bile acids, and blood ammonia.

That distinction matters clinically. A dog can have dramatically elevated ALT and ALP while still maintaining adequate liver function. A dog can also have near-normal enzyme levels while experiencing significant loss of functional liver mass in chronic fibrotic disease.

understanding dog blood work results

What Are the Signs of Liver Disease in Dogs?

The earliest signs of liver disease in dogs are often the ones easiest to attribute to something else. Decreased appetite, mild lethargy, occasional vomiting, subtle weight loss: these are not specific to hepatic disease and appear in dozens of conditions. That ambiguity is precisely why liver disease so frequently advances before it's diagnosed.

As disease progresses, the clinical picture sharpens. Polyuria and polydipsia (increased thirst and urination) develop because the failing liver cannot adequately regulate the hormones and metabolites that control renal water handling. Vomiting becomes more frequent, sometimes accompanied by diarrhea or pale, acholic stools when bile secretion is impaired. Weight loss accelerates. Dogs may develop a potbellied appearance from ascites (fluid accumulation in the abdomen), which occurs when portal hypertension and hypoalbuminemia combine to drive fluid out of the vascular space.

Hepatic encephalopathy is one of the most alarming and diagnostically striking signs. When the liver fails to convert ammonia to urea adequately, ammonia and other neurotoxins accumulate in the bloodstream and cross the blood-brain barrier. The resulting neurological signs range from mild (dullness, subtle behavioral change, slow responsiveness) to severe (head pressing, compulsive circling, ataxia, seizures, and coma). A dog that presses its head against a wall or walks in circles without obvious cause, particularly one with known or suspected liver disease, needs emergency evaluation immediately.

Worth knowing: Hepatic encephalopathy episodes are often precipitous and can look like acute neurological emergencies unrelated to the liver. Dogs presenting with sudden-onset seizures or stupor frequently receive neurological workups before anyone checks liver enzymes or blood ammonia. If your dog has any known liver history, always mention it first at an emergency visit, regardless of the presenting symptoms.

Jaundice, discussed in detail in the next section, represents a sign of significantly impaired bilirubin metabolism. Its appearance signals that liver disease has either progressed substantially or that an additional process (hemolysis or bile duct obstruction) is contributing.

signs of abdominal pain in dogs

What Does Jaundice in Dogs Really Mean?

Jaundice, called icterus in veterinary terminology, is the yellow discoloration of tissues caused by bilirubin accumulation in the body. In dogs, it's most readily visible in the whites of the eyes (sclera), the inner surface of the ears, the gums, and the skin of the belly. It can also turn the urine dark orange or brown.

Seeing jaundice in a dog is always a reason for urgent veterinary evaluation. It is not a disease itself; it is a sign that bilirubin is accumulating faster than it can be cleared. Three distinct mechanisms produce it, and distinguishing them drives the diagnostic plan.

Pre-hepatic jaundice occurs when red blood cell destruction (hemolysis) overwhelms the liver's ability to conjugate bilirubin, even when the liver itself is healthy. Immune-mediated hemolytic anemia is the most common cause in dogs. Hepatic jaundice occurs when the liver is directly damaged and cannot conjugate or excrete bilirubin normally, as in chronic hepatitis, toxic hepatopathy, or acute hepatic necrosis. Post-hepatic jaundice occurs when the bile duct is obstructed, preventing bilirubin excretion into the intestine; this can result from pancreatitis, bile duct mucocele, or neoplasia compressing the duct.

From the clinic: Owners often notice jaundice in the eyes first, particularly in natural light. The sclera takes on a yellow-orange tint that's subtle indoors but visible immediately outdoors. If you notice this in your dog and it's been present for more than a few hours, treat it as urgent, not something to monitor for another day. Jaundice reflects significantly impaired bilirubin metabolism and the underlying cause needs to be found quickly.

In all three categories, the degree of jaundice does not reliably correlate with the severity of the underlying disease.

immune-mediated hemolytic anemia in dogs A dog with mild extrahepatic biliary obstruction may appear more deeply icteric than a dog with severe chronic hepatitis that still has residual bilirubin clearance capacity. What matters is the category, not the depth of color.

<figcaption>The three categories of jaundice in dogs differ in mechanism, liver involvement, and clinical clues. Identifying the category drives the diagnostic and treatment plan.</figcaption> </figure>

Making Sense of Elevated Liver Enzymes in Dogs

Elevated liver enzymes on a bloodwork panel are one of the most common findings in canine medicine, and one of the most contextually misread. The first thing to understand is what the numbers actually measure: ALT and AST reflect hepatocyte damage; ALP and GGT reflect bile duct stress or cholestasis. None of them measure how well the liver is functioning.

ALP has a high sensitivity (86%) for canine liver disease but a poor specificity of only 49%, meaning roughly half of elevated ALP findings in dogs have a non-hepatic cause (Merck Veterinary Manual). Corticosteroid administration, whether prescribed or endogenous from Cushing's disease, produces a hepatic isoenzyme of ALP that can elevate the value dramatically without representing primary liver disease. Phenobarbital, used for seizure control, induces hepatic enzyme activity and causes ALP and ALT elevations as a direct drug effect. Some dogs have persistently mildly elevated enzymes that never progress to clinical disease.

The magnitude of elevation matters. Mild elevation, defined as 1 to 3 times the upper reference limit, is frequently incidental and may resolve with retesting after addressing any contributing factors. Moderate elevation, 3 to 10 times, is clinically significant and warrants investigation. Marked elevation, above 10 times the upper reference limit, represents active substantial hepatocellular injury and usually prompts urgent diagnostic workup. A persistently increased ALT over multiple testing intervals, even if mild, is more concerning than a single elevated reading, because it suggests an ongoing rather than transient process.

A distinction worth making: Elevated liver enzymes and impaired liver function are not the same finding. Some dogs with ALT ten times the upper limit have adequate liver function by every measure. Others with only mildly elevated ALT have lost so much functional hepatic mass through fibrosis that they are in impending failure. Function tests (serum albumin, bile acids, coagulation times, blood ammonia, bilirubin) tell the clinician what the liver is actually doing. Enzyme elevations tell you that hepatocytes are under stress. Both are needed to assess severity accurately.

A 2023 five-year follow-up study of dogs undergoing liver biopsy found that the predictors most strongly associated with two-year mortality were elevated serum GGT, hypoalbuminemia, and prolonged activated partial thromboplastin time (aPTT), not the raw magnitude of ALT or ALP (PMC10451749, 2023). Those markers reflect function, not just injury. They're the ones that carry prognostic weight.

<figcaption>Cumulative mortality in dogs with hepatobiliary disease following liver biopsy diagnosis. The steep five-year trajectory underscores why early identification and monitoring matter.</figcaption> </figure>

What Types of Liver Disease Affect Dogs Most?

Canine liver disease is not a single entity. The umbrella covers several distinct conditions with different causes, courses, and treatments, which is why a tissue diagnosis (biopsy) is usually necessary to guide management rather than treating on clinical impression alone.

Chronic hepatitis is the most frequently diagnosed liver condition in dogs. It involves progressive hepatic inflammation with fibrosis, varying degrees of hepatocyte death, and ultimately cirrhosis if untreated. In most cases the underlying cause is not identified, and treatment is empirical. Copper-associated hepatopathy has emerged as the dominant identified cause of chronic necroinflammatory liver disease in dogs in North America since dietary changes in the late 1990s. Of 4,559 liver biopsy cases reviewed in one large series, 50% had hepatic copper concentrations above 400 ppm (the threshold for concern), and 19% exceeded 1,000 ppm dry weight, the level at which copper becomes directly toxic to hepatocytes (PMC9708449, 2022). Breeds with established genetic copper metabolism defects include Bedlington Terriers, West Highland White Terriers, Doberman Pinschers, Dalmatians, and Labrador Retrievers, though the condition is increasingly recognized in breeds without known genetic variants, likely due to the widespread adoption of commercial diets with highly bioavailable copper.

Acute hepatotoxicity represents a separate category: sudden, severe liver cell damage from a toxin, drug, or infectious agent. Xylitol (found in sugar-free foods), certain mushroom species (particularly Amanita phalloides and related species), blue-green algae, and zinc ingestion from pennies or other objects are among the more common canine hepatotoxins. The clinical picture is rapid and severe, with vomiting, jaundice, and coagulopathy developing within hours to days of exposure.

Hepatic neoplasia, whether primary liver tumors (hepatocellular carcinoma being most common) or metastatic disease, accounts for a meaningful portion of hepatic presentations in older dogs. Primary hepatocellular carcinoma of the massive type (one large tumor involving one liver lobe) carries a surprisingly favorable prognosis after surgical resection: median survival after complete lobectomy exceeds two years in several studies. Diffuse or nodular hepatic involvement, by contrast, is rarely resectable and carries a poor prognosis.

Portosystemic shunts, which redirect blood around the liver rather than through it, cause significant hepatic encephalopathy but represent an anatomical problem rather than intrinsic hepatic disease. They're more common in young dogs and can often be surgically corrected.

copper in dog food and hepatic health

How Is Hepatic Disease Treated?

The treatment of liver disease in dogs is almost always guided by the underlying diagnosis, which is exactly why biopsy matters. Treating presumed chronic hepatitis with the same protocol as copper toxicity, or managing suspected immune-mediated disease the same way as a portosystemic shunt, produces poor outcomes. That said, several supportive measures apply broadly across hepatic conditions while the diagnostic picture is being completed.

Dietary management is the most universally applicable intervention. Liver disease diets emphasize moderate, highly digestible protein (to support hepatocellular regeneration without generating excessive ammonia), restricted sodium (to minimize ascites), adequate carbohydrates, and supplemental water-soluble vitamins that the failing liver cannot store adequately. Commercial hepatic veterinary diets are formulated to these parameters, but home-prepared diets can be used when properly designed by a veterinary nutritionist.

For copper-associated hepatopathy, the specific treatment involves a copper-restricted diet combined with chelation therapy (D-penicillamine) in dogs with substantially elevated hepatic copper. This combination reduces hepatic copper burden over months, with measurable ALT improvement in most dogs who maintain treatment compliance. The 2025 In Practice update on canine liver disease treatment emphasized that copper chelation produces better outcomes when initiated before severe fibrosis has developed, reinforcing the value of biopsy timing (In Practice, 2025).

Immunosuppressive therapy with corticosteroids is used in immune-mediated chronic hepatitis where copper accumulation and infectious causes have been excluded. Antioxidant support with S-adenosylmethionine (SAMe) and milk thistle (silymarin) is commonly incorporated across many hepatic conditions to reduce oxidative stress on remaining hepatocytes, though evidence for individual agents remains mixed. Ursodeoxycholic acid (ursodiol) improves bile flow and has hepatoprotective properties useful in cholestatic disease.

Ascites management requires diuretic therapy: spironolactone is the first-line choice, with furosemide added for refractory cases. Hepatic encephalopathy is managed acutely with lactulose (to trap ammonia in the colon) and dietary protein adjustment.

veterinary liver support supplements for dogs

When Liver Disease Becomes a Crisis

Most dogs with liver disease live in a state of managed, compensated dysfunction for months to years. The transition to decompensation can be gradual or abrupt, and recognizing the warning signs of deterioration saves critical time.

The presence of systemic inflammatory response syndrome (SIRS) in dogs with confirmed hepatitis is the strongest predictor of rapid deterioration. A PLOS ONE study of 70 dogs with histologically confirmed primary hepatitis found median survival of 231 days in those with a low SIRS score (0-1 criteria) compared to just 7 days in those meeting 2 or more SIRS criteria (PMC4726575, 2016). The implication is stark: systemic inflammation in a hepatic patient is not a complication to monitor. It is an emergency requiring immediate escalation of care.

The markers that predict two-year mortality across hepatobiliary disease types are hypoalbuminemia, elevated serum GGT, and prolonged clotting times. All three reflect loss of functional hepatic reserve, not just ongoing injury. When a dog with established liver disease begins showing declining albumin on repeat bloodwork, the trajectory has shifted. This is the point at which monitoring schedules should compress from months to weeks, and treatment plans should be reassessed with urgency.

Coagulopathy represents one of the most underappreciated complications of hepatic failure. Because the liver synthesizes most clotting factors, severe disease can produce a bleeding tendency that becomes clinically apparent as bruising, bloody stools, prolonged bleeding from minor cuts, or spontaneous hemorrhage. A dog scheduled for any procedure, including dental cleaning, should have pre-procedure coagulation testing if liver disease is known or suspected. The consequences of unrecognized coagulopathy in a surgical patient can be fatal.

Acute hepatic crisis in any dog, regardless of prior history, presents as rapid deterioration: profound lethargy, vomiting that won't stop, jaundice appearing within hours, neurological signs, or collapse. This presentation requires emergency care without delay.

emergency signs in dogs requiring immediate veterinary care

Frequently Asked Questions

The Organ You Don't Notice Until It Falters

Liver disease in dogs earns its reputation as a silent condition. It progresses for months through biochemical changes that cause no visible distress, and by the time the signs of liver disease in dogs become obvious, whether jaundice, ascites, weight loss, or neurological signs, the disease has typically reached a stage where treatment is more difficult and prognosis more guarded.

The clinical advantage belongs to the owner who understands what routine bloodwork is actually screening for, who recognizes that mildly elevated liver enzymes on an annual panel are worth tracking rather than dismissing, and who brings their dog in promptly when early signs appear. The liver's regenerative capacity is remarkable. Given the right conditions and the right timing, many dogs with hepatic disease stabilize, maintain quality of life, and live comfortably for years after diagnosis.

What the liver cannot do is recover from neglect indefinitely. The five-year mortality data are not a reason for pessimism; they are a reason to start the conversation early, run the diagnostics now, and give the treatment plan time to work before complications narrow the options.

monitoring bloodwork in dogs with liver disease